Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.420
-0.010 (-0.41%)
At close: Dec 5, 2025, 4:00 PM EST
2.440
+0.020 (0.83%)
After-hours: Dec 5, 2025, 7:34 PM EST
Editas Medicine Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -199.84 | -237.09 | -153.22 | -220.43 | -192.5 | -115.98 | |
| Depreciation & Amortization | 7.64 | 5.81 | 6.06 | 6.34 | 5.05 | 3.96 | |
| Loss (Gain) From Sale of Assets | 5.93 | 0.15 | - | - | - | - | |
| Asset Writedown & Restructuring Costs | -1.79 | - | - | - | - | 27.5 | |
| Loss (Gain) From Sale of Investments | -1.77 | -5.79 | -4.82 | -0.72 | 1.66 | -16.37 | |
| Stock-Based Compensation | 11.89 | 21.42 | 19.8 | 29.29 | 43.4 | 23.16 | |
| Other Operating Activities | 8.44 | 1.78 | 1.6 | - | - | 0.1 | |
| Change in Accounts Receivable | -8 | -6.08 | -5.04 | -4.88 | 5.78 | -5.63 | |
| Change in Accounts Payable | -9.33 | -2.29 | -1.49 | 4.37 | -1.14 | 0.86 | |
| Change in Unearned Revenue | -14.68 | -8.46 | - | -3.33 | -22.71 | -91.79 | |
| Change in Other Net Operating Assets | 21.9 | 20.28 | 4.94 | 12.02 | -3.35 | -5.65 | |
| Operating Cash Flow | -179.62 | -210.28 | -132.18 | -177.35 | -163.8 | -179.84 | |
| Capital Expenditures | -1.09 | -8.83 | -4.72 | -4.12 | -7.98 | -7.16 | |
| Sale of Property, Plant & Equipment | 0.15 | - | - | 0.02 | - | 0.01 | |
| Investment in Securities | 170.5 | 170.97 | 0.99 | 118.17 | -46.49 | -133.37 | |
| Investing Cash Flow | 169.57 | 162.15 | -3.73 | 114.07 | -54.47 | -140.52 | |
| Issuance of Common Stock | 26.29 | 0.78 | 118.04 | 1.28 | 282.11 | 224.12 | |
| Other Financing Activities | 52.37 | 55.24 | - | - | - | - | |
| Financing Cash Flow | 78.66 | 56.03 | 118.04 | 1.28 | 282.11 | 224.12 | |
| Net Cash Flow | 68.61 | 7.89 | -17.87 | -62 | 63.84 | -96.24 | |
| Free Cash Flow | -180.7 | -219.11 | -136.9 | -181.47 | -171.78 | -187.01 | |
| Free Cash Flow Margin | -389.59% | -678.06% | -175.23% | -920.59% | -672.49% | -206.11% | |
| Free Cash Flow Per Share | -2.12 | -2.66 | -1.80 | -2.64 | -2.54 | -3.19 | |
| Levered Free Cash Flow | -65.97 | -121.09 | -87.81 | -102.27 | -85.55 | -77.36 | |
| Unlevered Free Cash Flow | -61.82 | -121.09 | -87.81 | -102.27 | -85.55 | -77.36 | |
| Change in Working Capital | -10.12 | 3.45 | -1.59 | 8.18 | -21.41 | -102.22 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.